Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2362|45|4|423-440

ISSN: 0014-2972

Source: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol.45, Iss.4, 2015-04, pp. : 423-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract